Knight Therapeutics | GUD - 资产

股票价格

6.41

每天变化

0.11 1.75%

每月一次

-2.29%

每年

3.72%

Q1 预测

5.95

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 638.39M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	资产	更改		日
Acasti Pharma	USD 66.58M		3.22M	2025-09
Akebia Therapeutics	USD 376.56M		12.41M	2025-12
Alaunos Therapeutics	USD 3.72M		1.01M	2025-09
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Avita Medical	AUD 56.39M		1.74M	2025-12
Canopy Growth	CAD 1.11B		36.35M	2025-12
Cronos Group	USD 1.2B		18.73M	2025-12
Dianthus Therapeutics	USD 530.92M		46.52M	2025-12
Ionis Pharmaceuticals	USD 3.52B		490.91M	2025-12
IQVIA Holdings	USD 29.94B		1.22B	2025-12
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Moderna	USD 12.34B		203M	2025-12
Omeros	USD 200.57M		34.59M	2025-06
Organigram Holdings	CAD 530.67M		31.54M	2025-12
Organon & Co	USD 13.55B		52M	2025-09
Revvity	USD 12.17B		29.46M	2025-12
Tectonic Therapeutic	USD 261.04M		15.96M	2025-12
Tilray	USD 2.1B		15.95M	2025-09
Viatris	USD 37.19B		727.3M	2025-12
Xeris Pharmaceuticals	USD 383.53M		13.34M	2025-12